Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005)

被引：56
|
作者：
Pfaller, Michael A.
Sader, Helio S. [1 ]
Jones, Ronald N.
机构：
[1] JML Labs, N Liberty, IA 52317 USA
[2] Univ Iowa, Iowa City, IA 52242 USA
[3] Univ Fed Sao Paulo, Div Infect Dis, BR-04023900 Sao Paulo, Brazil
[4] Tufts Univ, Sch Med, Boston, MA 02111 USA
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2007年 / 57卷 / 04期
关键词：
daptomycin; gram-positive infections; Staphylococcus aureus; susceptibility;
D O I：
10.1016/j.diagmicrobio.2006.10.007
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
We evaluated the antimicrobial activity of daptomycin against 19 615 clinical strains consecutively collected by numerous centers located across the United States and Canada (2002-2005). Daptomycin was very active against all indicated species (>99% susceptible), with the highest MIC results being 2, 8, 0.5, and 1 mu g/mL for staphylococci, enterococci, beta-hemolytic streptococci, and viridans group streptococci, respectively, and no significant loss in potency was observed over the period studied. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码：459 / 465
页数：7
相关论文
共 50 条
  • [21] Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center
    Smith, PF
    Booker, BM
    Ogundele, AB
    Kelchin, P
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (03) : 255 - 259
  • [22] In Vitro Activity of Ceftaroline against Gram-Positive and Gram-Negative Pathogens Isolated from Patients in Canadian Hospitals in 2009
    Karlowsky, James A.
    Adam, Heather J.
    DeCorby, Melanie R.
    Lagace-Wiens, Philippe R. S.
    Hoban, Daryl J.
    Zhanel, George G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (06) : 2837 - 2846
  • [23] In vitro activity of linezolid and other antibiotics against Gram-positive bacteria from the major teaching hospitals in Kuwait
    Al Sweih, N
    Mokaddas, E
    Jamal, W
    Phillips, OA
    Rotimi, VO
    JOURNAL OF CHEMOTHERAPY, 2005, 17 (06) : 607 - 613
  • [24] In vitro activity of telavancin against recent Gram-positive clinical isolates:: results of the 2004-05 Prospective European Surveillance Initiative
    Draghi, Deborah C.
    Benton, Bret M.
    Krause, Kevin M.
    Thornsberry, Clyde
    Pillar, Chris
    Sahm, Daniel F.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (01) : 116 - 121
  • [25] In vitro activity of daptomycin versus linezolid and vancomycin against gram-positive uropathogens and ampicillin against enterococci, causing complicated urinary tract infections
    Wagenlehner, FME
    Lehn, N
    Witte, W
    Naber, KG
    CHEMOTHERAPY, 2005, 51 (2-3) : 64 - 69
  • [26] In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Gram-positive cocci isolated from surgical wound infections
    Simonetti, Oriana
    Morroni, Gianluca
    Ghiselli, Roberto
    Orlando, Fiorenza
    Brenciani, Andrea
    Xhuvelaj, Ledia
    Provinciali, Mauro
    Offidani, Annamaria
    Guerrieri, Mario
    Giacometti, Andrea
    Cirioni, Oscar
    JOURNAL OF MEDICAL MICROBIOLOGY, 2018, 67 (01) : 139 - 143
  • [27] Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001
    Critchley, IA
    Draghi, DC
    Sahm, DF
    Thornsberry, C
    Jones, ME
    Karlowsky, JA
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (03) : 639 - 649
  • [28] Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial
    Morfin-Otero, Rayo
    Noriega, Eduardo Rodriguez
    Dowzicky, Michael J.
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2015, 14
  • [29] Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004)
    Biedenbacha, Douglas J.
    Bellb, Jan M.
    Sadera, Helio S.
    Fritsche, Thomas R.
    Jones, Ronald N.
    Turnidge, John D.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 30 (02) : 143 - 149
  • [30] In Vitro Evaluation of the Antibacterial Activity of Three Different Central Venous Catheters Against Gram-Positive Bacteria
    K. Yorganci
    C. Krepel
    J. Weigelt
    C. Edmiston
    European Journal of Clinical Microbiology and Infectious Diseases, 2002, 21 : 379 - 384
12345